BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
The green tea modulates large intestinal microbiome and exo/endogenous metabolome altered through chronic UVB-exposure. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 12 Issue 11 Pages: e0187154 Pub: 2017 Epub: 2017 Nov 8 Authors Jung ES , Park HM , Hyun SM , Shon JC , Singh D , Liu KH , Whon TW , Bae JW , Hwang JS , Lee CH , |
|
|
Curated database of commensal, symbiotic and pathogenic microbiota ✅
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
Raw Bowl Tea (Tuocha) Polyphenol Prevention of Nonalcoholic Fatty Liver Disease by Regulating Intestinal Function in Mice. ✅
Biomolecules (Biomolecules ) Vol: 9 Issue 9 Pages: Pub: 2019 Sep 1 Epub: 2019 Sep 1 Authors Liu B , Zhang J , Sun P , Yi R , Han X , Zhao X , |
|
|
Green tea polyphenol (epigallocatechin-3-gallate) improves gut dysbiosis and serum bile acids dysregulation in high-fat diet-fed mice. ✅
Go to Publication ✅
Journal of clinical biochemistry and nutrition (J Clin Biochem Nutr ) Vol: 65 Issue 1 Pages: 34-46 Pub: 2019 Jul Epub: 2019 Apr 6 Authors Ushiroda C , Naito Y , Takagi T , Uchiyama K , Mizushima K , Higashimura Y , Yasukawa Z , Okubo T , Inoue R , Honda A , Matsuzaki Y , Itoh Y , |
|
|
Epigallocatechin gallate alleviates osteoporosis by regulating the gut microbiota and serum metabolites in rats. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 14 Issue 23 Pages: 10564-10580 Pub: 2023 Nov 27 Epub: 2023 Nov 27 Authors Han X , Fu Y , Wang K , Li S , Jiang C , Wang S , Wang Z , Liu G , Hu S , |
|
|
Amelioration of cognitive impairment using epigallocatechin-3-gallate in ovariectomized mice fed a high-fat diet involves remodeling with Prevotella and Bifidobacteriales. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 13 Issue Pages: 1079313 Pub: 2022 Epub: 2023 Jan 4 Authors Qu Y , Wu Y , Cheng W , Wang D , Zeng L , Wang Y , Li T , Zhang L , Yang J , Sun L , Ai J , |
|
|
Tea polyphenol and epigallocatechin gallate ameliorate hyperlipidemia via regulating liver metabolism and remodeling gut microbiota. ✅
Go to Publication ✅
Food chemistry (Food Chem ) Vol: 404 Issue Pt A Pages: 134591 Pub: 2023 Mar 15 Epub: 2022 Oct 14 Authors Wen JJ , Li MZ , Chen CH , Hong T , Yang JR , Huang XJ , Geng F , Hu JL , Nie SP , |
|
|
Dietary Epigallocatechin-3-Gallate Alters the Gut Microbiota of Obese Diabetic db/db Mice: Lactobacillus Is a Putative Target. ✅
Go to Publication ✅
Journal of medicinal food (J Med Food ) Vol: 23 Issue 10 Pages: 1033-1042 Pub: 2020 Oct Epub: Authors Park JM , Shin Y , Kim SH , Jin M , Choi JJ , |
|
|
Dietary Epigallocatechin-3-Gallate Alters the Gut Microbiota of Obese Diabetic db/db Mice: Lactobacillus Is a Putative Target. ✅
Go to Publication ✅
Journal of medicinal food (J Med Food ) Vol: 23 Issue 10 Pages: 1033-1042 Pub: 2020 Oct Epub: Authors Park JM , Shin Y , Kim SH , Jin M , Choi JJ , |
|
|
Reciprocal Interactions between Epigallocatechin-3-gallate (EGCG) and Human Gut Microbiota In Vitro. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 68 Issue 36 Pages: 9804-9815 Pub: 2020 Sep 9 Epub: 2020 Aug 26 Authors Liu Z , de Bruijn WJC , Bruins ME , Vincken JP , |
|
|
Reciprocal Interactions between Epigallocatechin-3-gallate (EGCG) and Human Gut Microbiota In Vitro. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 68 Issue 36 Pages: 9804-9815 Pub: 2020 Sep 9 Epub: 2020 Aug 26 Authors Liu Z , de Bruijn WJC , Bruins ME , Vincken JP , |
|
|
Polysaccharide from Ziyang Selenium-Enriched Green Tea Prevents Obesity and Promotes Adipose Thermogenesis via Modulating the Gut Microbiota. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 71 Issue 36 Pages: 13363-13375 Pub: 2023 Sep 13 Epub: 2023 Aug 30 Authors Li D , Cheng Y , Zeng X , Li Y , Xia Z , Yang X , Ren D , |
|
|
Differential regulation and preventive mechanisms of green tea powder with different quality attributes on high-fat diet-induced obesity in mice. ✅
Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 9 Issue Pages: 992815 Pub: 2022 Epub: 2022 Sep 29 Authors Wang J , Dong L , Hu JQ , Wang YY , Li A , Peng B , Zhang BW , Liu JM , Wang S , |
|
|
Green tea extract alters gut microbiota and their metabolism of adults with metabolic syndrome in a host-free human colonic model. ✅
Go to Publication ✅
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 160 Issue Pages: 111762 Pub: 2022 Oct Epub: 2022 Jul 30 Authors Zhang S , Xu M , Sun X , Shi H , Zhu J , |
|
|
Epigallocatechin-3-gallate reduces liver and immune system damage in Acinetobacter baumannii-loaded mice with restraint stress. ✅
Go to Publication ✅
International immunopharmacology (Int Immunopharmacol ) Vol: 92 Issue Pages: 107346 Pub: 2021 Mar Epub: 2021 Jan 4 Authors Yan Q , Hao S , Shi F , Zou Y , Song X , Li L , Li Y , Guo H , He R , Zhao L , Ye G , Tang H , |
|
|
Antibacterial activity of epigallocatechin-3-gallate (EGCG) and its synergism with ß-lactam antibiotics sensitizing carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii. ✅
Go to Publication ✅
Phytomedicine : international journal of phytotherapy and phytopharmacology (Phytomedicine ) Vol: 24 Issue Pages: 49-55 Pub: 2017 Jan 15 Epub: 2016 Nov 17 Authors Lee S , Razqan GS , Kwon DH , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
